Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children
Stroke - United States
doi 10.1161/strokeaha.107.510164
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)